Miller Andrew Craig
- SEC CIK
- 0001777760
No open-market purchases or sales filed in the past year.
Current role at each company
- ANRO Alto Neuroscience, Inc.Directoras of May 29, 2026
- KYTX Kyverna Therapeutics, Inc.Directoras of Mar 4, 2026
- KRTX Karuna Therapeutics, Inc.President of R&Das of Mar 18, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Miller Andrew Craig as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KRTX Karuna Therapeutics, Inc.
President of R&D8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2023 (view filing) | Apr 18-20 | 2 days | Miller Andrew CraigChief Operating Officer | SSale | −45.0K | $200.15 | −$9.01M | −64.8%24.4K after | 2 lots10b5-1 |
| Dec 2, 2022 (view filing) | Dec 1 | 1 day | Miller Andrew CraigChief Operating Officer | SSale | −15.0K | $228.30 | −$3.42M | −57.1%11.3K after | |
| Nov 14, 2022 (view filing) | Nov 10 | 4 days | Miller Andrew CraigChief Operating Officer | SSale | −15.0K | $225.98 | −$3.39M | −37.0%25.5K after | |
| Nov 3, 2022 (view filing) | Nov 1 | 2 days | Miller Andrew CraigChief Operating Officer | SSale | −15.0K | $225.08 | −$3.38M | −28.0%38.5K after | |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Miller Andrew CraigChief Operating Officer | SSale | −2.83K | $142.03 | −$401.5K | −5.2%51.5K after | 6 lots |
| Oct 5, 2021 (view filing) | Oct 1-4 | 4 days | Miller Andrew CraigChief Operating Officer | SSale | −16.5K | $124.36 | −$2.05M | −37.2%27.8K after | 7 lots |
| Sep 3, 2021 (view filing) | Sep 1-2 | 2 days | Miller Andrew CraigChief Operating Officer | SSale | −8.17K | $120.78 | −$987.2K | −15.6%44.3K after | 4 lots |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Miller Andrew CraigChief Operating Officer | SSale | −5.50K | $103.92 | −$571.6K | −9.5%52.5K after | 3 lots |